Evaluation and management of thyrotropin-secreting pituitary adenomas
| Autor: | Nicholas A. Tritos, Maya Barake |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Anterior hypopituitarism
endocrine system Economics and Econometrics medicine.medical_specialty endocrine system diseases business.industry medicine.medical_treatment Forestry Pituitary neoplasm Bioinformatics medicine.disease Dopamine agonist Somatostatin Receptor Agonist Radiation therapy Endocrinology Dopamine Pituitary adenoma Internal medicine Materials Chemistry Media Technology medicine Differential diagnosis business hormones hormone substitutes and hormone antagonists medicine.drug |
| Zdroj: | International Journal of Endocrine Oncology. 1:163-171 |
| ISSN: | 2045-0877 2045-0869 |
| DOI: | 10.2217/ije.14.15 |
| Popis: | Thyrotropin (TSH)-secreting pituitary adenomas are uncommon pituitary neoplasms. They have been increasingly recognized with the advent of ultrasensitive TSH assays and advanced pituitary imaging. Clinically, patients may often present with signs and symptoms of hyperthyroidism. Some patients may present with tumor-related local mass effect, anterior hypopituitarism or syndromes related to co-secretion of other pituitary hormones. Their diagnosis and differential diagnosis from other causes of hyperthyroidism and ‘inappropriate TSH secretion’ often presents a clinical challenge. While trans-sphenoidal pituitary adenomectomy remains the therapeutic modality of choice, medical treatment with somatostatin receptor agonists or dopamine agonists is often needed as adjunctive therapy or perhaps as a potential alternative to surgery. Radiation therapy to the sella may be advised as a third-line therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|